Japan Medical Dynamic Marketing, Inc.
7600.T · JPX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.54 | 0.01 | 0.15 | -1.15 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 31.55 | -14.24 | 17.23 | 32.32 |
| Quality | ||||
| ROIC | 0.36% | 1.00% | 1.37% | 0.81% |
| Gross Margin | 55.80% | 54.26% | 62.90% | 58.46% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 3.80% | 4.83% | 5.63% | 5.75% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 3.71 | -0.10 | 0.40 | 0.31 |
| Interest Coverage | 3.50 | 10.93 | 26.25 | 24.97 |
| Efficiency | ||||
| Inventory Turnover | 0.18 | 0.22 | 0.17 | 0.18 |
| Cash Conversion Cycle | 532.39 | 454.01 | 574.48 | 550.64 |